Sino Biological,Inc. (SHE:301047)
China flag China · Delayed Price · Currency is CNY
73.64
-0.51 (-0.69%)
At close: Apr 21, 2026

Sino Biological,Inc. Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
8,9578,2237,52310,64612,87623,508
Market Cap Growth
15.42%9.30%-29.33%-17.32%-45.23%-
Enterprise Value
5,7895,0133,6845,9476,91517,218
Last Close Price
73.6467.6057.7974.9788.81157.68
PE Ratio
60.6355.6661.7040.9342.5032.65
Forward PE
50.7952.8142.2234.4138.7820.76
PS Ratio
12.8011.7512.2616.4722.4124.35
PB Ratio
1.691.551.301.672.023.48
P/TBV Ratio
1.791.651.381.672.023.48
P/FCF Ratio
198.42182.15171.82-137.9539.53
P/OCF Ratio
61.2756.2566.1533.0151.6336.58
EV/Sales Ratio
8.277.176.009.2012.0417.84
EV/EBITDA Ratio
31.9529.5339.0832.6731.2524.29
EV/EBIT Ratio
64.1748.01125.7943.8033.9824.72
EV/FCF Ratio
128.23111.0584.15-74.0928.95
Debt / Equity Ratio
0.010.010.010.010.010.01
Debt / EBITDA Ratio
0.310.310.560.420.290.07
Debt / FCF Ratio
1.191.191.54-0.760.08
Net Debt / Equity Ratio
-0.60-0.60-0.67-0.75-0.90-0.96
Net Debt / EBITDA Ratio
-18.67-18.67-41.17-26.17-25.90-9.12
Net Debt / FCF Ratio
-70.19-70.19-88.666.61-61.41-10.87
Asset Turnover
0.120.120.100.100.090.23
Inventory Turnover
2.602.602.922.522.633.54
Quick Ratio
22.3222.3220.8636.6447.6067.82
Current Ratio
23.0323.0321.3037.1748.1268.30
Return on Equity (ROE)
2.67%2.67%2.01%4.08%4.62%17.89%
Return on Assets (ROA)
1.13%1.13%0.29%1.29%1.89%10.42%
Return on Invested Capital (ROIC)
4.08%4.26%1.45%10.95%38.86%234.42%
Return on Capital Employed (ROCE)
1.90%1.90%0.50%2.10%3.20%10.30%
Earnings Yield
1.65%1.80%1.62%2.44%2.35%3.06%
FCF Yield
0.50%0.55%0.58%-6.77%0.73%2.53%
Dividend Yield
7.01%-1.73%2.67%2.25%3.34%
Payout Ratio
411.67%411.67%209.57%99.33%224.45%-
Buyback Yield / Dilution
4.93%4.93%0.97%-13.44%-5.79%-11.11%
Total Shareholder Return
10.25%4.93%2.71%-10.77%-3.54%-7.77%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.